The antiviral effect of human interferon alpha is dependent on phosphoinositide-derived messengers.
Neomycin the putative blocker of membrane polyphosphoinositide hydrolysis, inhibited the antiviral activity of human interferon alpha, when tested on human quiescent fibroblasts challenged with vesicular stomatitis virus. The anti-interferon effect of neomycin could be correlated in terms of dose dependence for both neomycin (0.05-1 mM) and interferon (100-5,000 IU/ml). The results suggest that the antiviral activity of interferon alpha depends on diacylglycerol formation. Indeed, the synthetic diacylglycerol (50 microM) was as effective as 100 IU/ml interferon in inducing the antiviral state.
Cernescu
C
C
Stefan S. Nicolau Institute of Virology, Bucharest, Romania.
Constantinescu
S N
SN
Baltă
F
F
Popescu
L M
LM
D002478:Cells, Cultured; D004305:Dose-Response Relationship, Drug; D006801:Humans; D006868:Hydrolysis; D007370:Interferon Type I / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D009355:Neomycin / Q000494:pharmacology; D010716:Phosphatidylinositols / Q000037:antagonists & inhibitors / Q000378:metabolism*; D014721:Vesicular stomatitis Indiana virus / Q000187:drug effects*
D007370:Interferon Type I; D010716:Phosphatidylinositols; D009355:Neomycin